Safety and efficacy of 3 DMARDs for 2 years of treatment in patients with early rheumatoid arthritis
Phase of Trial: Phase IV
Latest Information Update: 07 Feb 2015
At a glance
- Drugs Bucillamine (Primary) ; Methotrexate; Sulfasalazine
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms TRED
- 07 Feb 2015 According to UMIN, the date for data entry closure is 31 Aug 2013, and the date for conclusion of data analysis is 31 Dec 2013.
- 18 Jul 2013 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 07 Jan 2013 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.